Senate Bill 518
116th Congress(2019-2020)
Lymphedema Treatment Act
Introduced
Introduced
Introduced in Senate on Feb 14, 2019
Overview
Text
Introduced
Feb 14, 2019
Latest Action
Feb 14, 2019
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
518
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Washington
Missouri
Arkansas
Arkansas
California
Connecticut
Delaware
Delaware
Florida
Illinois
Indiana
Maryland
Massachusetts
Massachusetts
Michigan
Minnesota
Minnesota
Mississippi
Mississippi
Missouri
Montana
Nebraska
New Hampshire
New Hampshire
New Jersey
New Jersey
New Mexico
New Mexico
North Carolina
North Dakota
North Dakota
Oklahoma
Pennsylvania
Rhode Island
Rhode Island
South Carolina
South Carolina
South Dakota
Virginia
Virginia
Alabama
Washington
Wisconsin
Wisconsin
No Senate votes have been held for this bill.
Summary

Lymphedema Treatment Act

This bill includes certain lymphedema compression treatment items as covered durable medical equipment under Medicare. (Lymphedema is a condition of localized fluid retention and tissue swelling that is caused when the lymphatic system is damaged or blocked.)

Text (1)
February 14, 2019
Actions (2)
02/14/2019
Read twice and referred to the Committee on Finance.
02/14/2019
Introduced in Senate
Public Record
Created
Feb 15, 2019 12:40:21 PM
Updated
Jun 11, 2021 9:58:04 PM